Smith+Nephew launch next generation LEAF™ Patient Monitoring System – an innovative pressure injury prevention platform delivering proven clinical impact

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the US launch of next generation LEAF ♢ Patient Monitoring System, a data-driven pressure injury prevention platform designed to help health care providers tackle the growing burden of hospital-acquired pressure injuries (HAPIs) by strengthening protocols and outcomes. The LEAF System uses a wearable sensor to monitor patient mobility and provide real-time turn status updates, helping to improve workflow efficiency, turn quality, and protocol adherence.1-3

GlobeNewsWire • Jun 1, 2026

VEEV Boosts MedTech Quality Management With Smith+Nephew Partnership

Veeva Systems expands its medtech reach as Smith+Nephew adopts Veeva Quality Cloud to modernize global quality operations and training.

Zacks Investment Research • May 13, 2026

UK's Smith+Nephew keeps annual outlook, plans share buyback as quarterly revenue rises

Medical products maker ​Smith+Nephew posted ‌a 3.1% rise ​in ​first-quarter underlying revenue on ⁠Wednesday, ​helped by ​strong sports medicine and wound ​management ​performance, and kept ‌its ⁠annual outlook unchanged while announcing ​a $500 ​million ⁠share buyback.

Reuters • May 6, 2026

Smith & Nephew plc (SNN) Q1 2026 Sales/Trading Call Transcript

Smith & Nephew plc (SNN) Q1 2026 Sales/Trading Call Transcript

Seeking Alpha • May 6, 2026

Smith+Nephew drives progress in chronic wound care with ALLEVYN™COMPLETE CARE Dressing and RENASYS™ EDGE tNPWT set to launch at EWMA 2026

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, continues to drive progress in chronic wound management with an industry-leading portfolio set to showcase at the upcoming European Wound Management Association (EWMA) Conference, Bremen between 6-8 May 2026.

GlobeNewsWire • May 5, 2026

SNN vs. BSX: Which Stock Is the Better Value Option?

Investors interested in Medical - Products stocks are likely familiar with Smith & Nephew (SNN) and Boston Scientific (BSX). But which of these two stocks presents investors with the better value opportunity right now?

Zacks Investment Research • May 5, 2026

SNN's CARTIHEAL Cartilage Implant Beats Standard Care in 5-Year Study

Smith+Nephew's CARTIHEAL implant shows superior 5-year outcomes vs. standard care, with a new CPT code set to boost adoption and expand cartilage repair reach.

Zacks Investment Research • Apr 24, 2026

SNN Launches ALLEVYN COMPLETE CARE Dressing for Wound Management

Smith + Nephew launches ALLEVYN COMPLETE CARE foam dressing for wound management, expanding its Advanced Wound Management portfolio.

Zacks Investment Research • Mar 11, 2026

Smith+Nephew launches next-generation ALLEVYN™ COMPLETE CARE Foam Dressing - designed for high performance in wound management and pressure injury prevention

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, recently announced the launch of ALLEVYN♢ COMPLETE CARE Foam Dressing, featuring proprietary technologies and performance backed by a portfolio of strong scientific data and clinical evidence.

GlobeNewsWire • Mar 10, 2026

Smith+Nephew to showcase advanced Orthopaedic Handheld Robotics, Reconstruction and Trauma technologies during AAOS 2026

Smith+Nephew announces it will feature handheld robotics during the American Academy of Orthopedic Surgeons (AAOS) Annual meeting in New Orleans this week.

GlobeNewsWire • Mar 3, 2026